Chinese American Cancer Survivors Writing Study

Description

The Chinese American Cancer Survivors Writing Study is a Randomized Controlled Trial (RCT) testing the feasibility and efficacy of the Expressive Helping (EH) intervention among Chinese American cancer survivors.

Conditions

Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

The Chinese American Cancer Survivors Writing Study is a Randomized Controlled Trial (RCT) testing the feasibility and efficacy of the Expressive Helping (EH) intervention among Chinese American cancer survivors.

A Randomized Controlled Trial Testing Expressive Helping for Chinese American Cancer Survivors

Chinese American Cancer Survivors Writing Study

Condition
Cancer
Intervention / Treatment

-

Contacts and Locations

New York

New York University, New York, New York, United States, 10003

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Over 18 years old.
  • * Prefer speaking in Mandarin Chinese or Cantonese, and able to read and write Simplified or Traditional Chinese.
  • * Within 5 years after completing primary treatment or have completed primary treatment but still on medication for managing cancer-related symptoms.
  • * Difficulties with writing
  • * Current active participation in support groups (i.e., attending more than once per week)

Ages Eligible for Study

18 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

New York University,

Study Record Dates

2025-07-31